02124nas a2200253 4500000000100000008004100001260004200042653001500084653001100099653001100110653002800121653000900149653002000158653003000178653002900208100001600237700001400253245006100267856005200328300001100380490000700391520145800398022001401856 2012 d c2012 May-JunbScieloaRio De Janeiro 10aAdolescent10aFemale10aHumans10aLeprosy, Paucibacillary10aMale10aQuality of Life10aSeverity of Illness Index10aSkin Diseases, Bacterial1 aBottene IMC1 aReis VMSD00aQuality of life of patients with paucibacillary leprosy. uhttp://www.scielo.br/pdf/abd/v87n3/v87n3a09.pdf a408-110 v873 a

BACKGROUND: Leprosy, an infectious disease caused by Mycobacterium leprae, can affect the skin and the peripheral nervous system and, depending on the level of involvement, it can lead to severe deformities. Leprosy is classified into two major groups: paucibacillary (up to five lesions) and multibacillary (more than five lesions). The deformities that appear during the progress of the disease can affect the quality of life.

OBJECTIVE: To assess quality of life of patients with paucibacillary leprosy diagnosed and treated early in the outpatients' clinic.

METHODS: The Dermatology Life Quality Index questionnaire and ShortForm36 were applied to 49 outpatients undergoing treatment at the Leprosy Multidisciplinary Group of the Hospital das Clínicas of the Faculdade de Medicina of the Universidade de São Paulo.

RESULTS: The majority of the patients (63%) did not show impairment of the quality of life, according to the results obtained by the Dermatology Life Quality Index questionnaire. In the questionnaire Short Form-36, the scores assessed showed slight impairment of the quality of life.

CONCLUSION: On this study, we can conclude that this group of patients, with paucibacillary leprosy, did not show important impairment of the quality of life. Therefore we can conclude that the earlier the diagnosis and the treatment the lesser the influence on the quality of life.

 a1806-4841